Carlo M. Croce

Carlo M. Croce's research focuses on how small RNA molecules called microRNAs contribute to cancer development, particularly in blood cancers like leukemia and lymphoma, as well as other solid tumors. His work explores microRNAs as tumor suppressors or drivers of disease, and investigates how targeting cell-death pathways and specific proteins (such as BCL-2 family members and receptor tyrosine kinases) could lead to new cancer therapies. Students in this group would likely engage with molecular biology techniques studying gene regulation, cancer cell biology, and translational applications toward diagnostics and treatment.

Publication counts were fairly steady through the late 2010s and early 2020s, spiked sharply in 2023 (likely due to a batch of dataset/supplementary-material entries), and have since dropped to a lower, more modest level in 2024-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026